During the past decade, Oncologianova GmbH conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 9 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oncologianova GmbH" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Pfizer" with 2 trials sponsored, "Alliance Foundation Trials, LLC." with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncologianova GmbH" #1 collaborator was "NSABP Foundation Inc" with 3 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 2 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "German Breast Group" with 2 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Oncologianova GmbH" are "Breast Cancer" (6 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Breast Neoplasms" (2 trials), "Triple Negative Breast Cancer" (2 trials) and "Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Oncologianova GmbH" in a lesser frequency.

Most popular intervention types in "Oncologianova GmbH" are "Drug" (21 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Carboplatin" (4 trials), "Cyclophosphamide" (3 trials), "Pemetrexed" (3 trials) and "Amivantamab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Oncologianova GmbH" are 20 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Oncologianova GmbH". undefined are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Oncologianova GmbH, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oncologianova GmbH, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".